Free tool
FAERS Monitor: Lithium Carbonate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018558 or its brand name (Lithium Carbonate, Lithium Carbonate). Reports on generic versions are filed under their own applications.
Reports
16,493
Serious
13,263
80% of reports
Hospitalization
7,052
Death reported
1,210
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- toxicity to various agents1,246
- drug ineffective1,124
- tremor1,066
- drug interaction999
- nausea811
- weight increased794
- insomnia698
- depression693
- fatigue671
- vomiting663
- confusional state636
- somnolence627
- anxiety596
- off label use590
- suicide attempt578
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 530 |
| 2005 | 452 |
| 2006 | 746 |
| 2007 | 1,023 |
| 2008 | 723 |
| 2009 | 826 |
| 2010 | 798 |
| 2011 | 1,114 |
| 2012 | 1,406 |
| 2013 | 499 |
| 2014 | 398 |
| 2015 | 615 |
| 2016 | 694 |
| 2017 | 584 |
| 2018 | 717 |
| 2019 | 677 |
| 2020 | 687 |
| 2021 | 762 |
| 2022 | 740 |
| 2023 | 723 |
| 2024 | 654 |
| 2025 | 594 |
| 2026 | 531 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,666 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| suicide attemptSignal | 578 | 12.3 | 11.3 | 5,929 |
| toxicity to various agentsSignal | 1,246 | 9.5 | 9.0 | 9,455 |
| tremorSignal | 1,066 | 8.2 | 7.8 | 6,781 |
| drug interactionSignal | 999 | 8.1 | 7.6 | 6,193 |
| confusional stateSignal | 636 | 5.0 | 4.7 | 2,060 |
| weight increasedSignal | 794 | 4.5 | 4.2 | 2,199 |
| somnolenceSignal | 627 | 4.0 | 3.7 | 1,405 |
| depressionSignal | 693 | 3.9 | 3.6 | 1,499 |
| insomniaSignal | 698 | 3.3 | 3.1 | 1,159 |
| anxietySignal | 596 | 2.7 | 2.5 | 630 |
| vomiting | 663 | 1.8 | 1.7 | 240 |
| nausea | 811 | 1.3 | 1.2 | 60 |
| fatigue | 671 | 1.1 | 1.0 | 6 |
| drug ineffective | 1,124 | 1.1 | 1.0 | 8 |
| off label use | 590 | 0.9 | 0.8 | 14 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.